These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 34082123)

  • 41. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.
    Schmidt DE; Ebert MH; Lynn JC; Whetsell WO
    J Neural Transm (Vienna); 1997; 104(8-9):875-85. PubMed ID: 9451719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants of dopaminergic neuron loss in Parkinson's disease.
    Surmeier DJ
    FEBS J; 2018 Oct; 285(19):3657-3668. PubMed ID: 30028088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MPP(+) -dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons.
    Masi A; Narducci R; Landucci E; Moroni F; Mannaioni G
    Br J Pharmacol; 2013 May; 169(1):130-42. PubMed ID: 23323755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-β-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons.
    Zarate SM; Pandey G; Chilukuri S; Garcia JA; Cude B; Storey S; Salem NA; Bancroft EA; Hook M; Srinivasan R
    J Neurochem; 2021 May; 157(3):710-726. PubMed ID: 33354763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.
    Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW
    Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease.
    Baranyi M; Porceddu PF; Gölöncsér F; Kulcsár S; Otrokocsi L; Kittel Á; Pinna A; Frau L; Huleatt PB; Khoo ML; Chai CL; Dunkel P; Mátyus P; Morelli M; Sperlágh B
    Mol Neurodegener; 2016 Jan; 11():6. PubMed ID: 26758813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease.
    Ray A; Kambali M; Ravindranath V
    Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
    Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
    Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation.
    Pinto M; Nissanka N; Peralta S; Brambilla R; Diaz F; Moraes CT
    Mol Neurodegener; 2016 Apr; 11():25. PubMed ID: 27038906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction.
    Suda Y; Kuzumaki N; Sone T; Narita M; Tanaka K; Hamada Y; Iwasawa C; Shibasaki M; Maekawa A; Matsuo M; Akamatsu W; Hattori N; Okano H; Narita M
    Mol Brain; 2018 Feb; 11(1):6. PubMed ID: 29458391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression.
    Siddiqui A; Mallajosyula JK; Rane A; Andersen JK
    Neurobiol Dis; 2010 Nov; 40(2):444-8. PubMed ID: 20655384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-fat diet exacerbates 1-Bromopropane-induced loss of dopaminergic neurons in the substantia nigra of mice through mitochondrial damage associated necroptotic pathway.
    Song M; Qiang Y; Wang S; Shan S; Zhang L; Liu C; Song F; Zhao X
    Ecotoxicol Environ Saf; 2024 May; 276():116280. PubMed ID: 38574648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
    Anandhan A; Tamilselvam K; Radhiga T; Rao S; Essa MM; Manivasagam T
    Brain Res; 2012 Jan; 1433():104-13. PubMed ID: 22138428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
    Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
    Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration.
    Deng Y; Jiao C; Mi C; Xu B; Li Y; Wang F; Liu W; Xu Z
    Mol Neurobiol; 2015 Feb; 51(1):68-88. PubMed ID: 24969583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
    Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
    Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neonatal 6-OHDA lesion of the SNc induces striatal compensatory sprouting from surviving SNc dopaminergic neurons without VTA contribution.
    Tanguay W; Ducrot C; Giguère N; Bourque MJ; Trudeau LE
    Eur J Neurosci; 2021 Oct; 54(7):6618-6632. PubMed ID: 34470083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine-degrading activity of monoamine oxidase is not detected by histochemistry in neurons of the substantia nigra pars compacta of the rat.
    Arai R; Horiike K; Hasegawa Y
    Brain Res; 1998 Nov; 812(1-2):275-8. PubMed ID: 9813366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.